SMSPHARMA.NSSMSPHARMA.NSNSE
Loading
Cash Flow Under PressureContracting
Percentile Rank47
3Y CAGR+23.5%
5Y CAGR-14.1%
Studio
Year-over-Year Change

Cash generated from core business operations

3Y CAGR
+23.5%/yr
vs -18.0%/yr prior
5Y CAGR
-14.1%/yr
Recent acceleration
Acceleration
+41.6pp
Accelerating
Percentile
P47
Within normal range
vs 5Y Ago
0.5x
Contraction
Streak
1 yr
Consecutive declineContracting
PeriodValueYoY Change
TTM$423.25M-34.4%
2025$645.23M+28.7%
2024$501.25M+123.3%
2023$224.50M-44.2%
2022$402.34M-55.5%
2021$904.53M+127.8%
2020$397.12M-20.2%
2019$497.57M+56.4%
2018$318.15M-66.2%
2017$941.46M-